Vanda Pharmaceuticals (VNDA) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -0.31% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -1.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.27% |
| Dec 31, 2025 | -4.40% |
| Sep 30, 2025 | -1.75% |
| Jun 30, 2025 | -4.13% |
| Mar 31, 2025 | -5.79% |
| Dec 31, 2024 | -11.85% |
| Sep 30, 2024 | -13.09% |
| Jun 30, 2024 | -14.08% |
| Mar 31, 2024 | -15.63% |
| Dec 31, 2023 | -21.03% |
| Sep 30, 2023 | -18.43% |
| Jun 30, 2023 | -16.70% |
| Mar 31, 2023 | -15.57% |
| Dec 31, 2022 | -12.68% |
| Sep 30, 2022 | -14.54% |
| Jun 30, 2022 | -13.48% |
| Mar 31, 2022 | -12.09% |
| Dec 31, 2021 | -11.01% |
| Sep 30, 2021 | -10.18% |
| Jun 30, 2021 | -8.88% |
| Mar 31, 2021 | -9.06% |
| Dec 31, 2020 | -7.97% |
| Sep 30, 2020 | -10.38% |
| Jun 30, 2020 | -13.12% |
| Mar 31, 2020 | -10.79% |
| Dec 31, 2019 | -8.32% |
| Sep 30, 2019 | -4.23% |
| Jun 30, 2019 | -0.05% |
| Mar 31, 2019 | -0.44% |
| Dec 31, 2018 | -1.13% |
| Sep 30, 2018 | 3.26% |
| Jun 30, 2018 | 7.45% |
| Mar 31, 2018 | 18.34% |
| Dec 31, 2017 | 29.61% |
| Sep 30, 2017 | 34.62% |
| Jun 30, 2017 | 35.16% |
| Mar 31, 2017 | 35.24% |
| Dec 31, 2016 | 31.65% |
| Sep 30, 2016 | 30.97% |
| Jun 30, 2016 | 24.35% |
| Mar 31, 2016 | 24.33% |
| Dec 31, 2015 | 24.86% |
| Sep 30, 2015 | 19.36% |
| Jun 30, 2015 | 15.17% |
| Mar 31, 2015 | 7.52% |
| Dec 31, 2014 | 36.23% |
| Sep 30, 2014 | 37.93% |
| Jun 30, 2014 | 33.90% |
| Dec 31, 2013 | 32.87% |